These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1220 related items for PubMed ID: 23633304

  • 1. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N, Tsoulis DJ, MacDonald JK.
    Cochrane Database Syst Rev; 2013 Apr 30; (4):CD000545. PubMed ID: 23633304
    [Abstract] [Full Text] [Related]

  • 2. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N, Townsend CM, Parker CE, MacDonald JK.
    Cochrane Database Syst Rev; 2016 Oct 26; 10(10):CD000545. PubMed ID: 27783843
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Wang Y, Tsoulis DJ, MacDonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2014 Aug 06; 2014(8):CD003459. PubMed ID: 25099640
    [Abstract] [Full Text] [Related]

  • 5. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Chande N, Patton PH, Tsoulis DJ, Thomas BS, MacDonald JK.
    Cochrane Database Syst Rev; 2015 Oct 30; 2015(10):CD000067. PubMed ID: 26517527
    [Abstract] [Full Text] [Related]

  • 6. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M, Taylor K, Akobeng AK, Thomas AG.
    Cochrane Database Syst Rev; 2014 Aug 01; 2014(8):CD010233. PubMed ID: 25081347
    [Abstract] [Full Text] [Related]

  • 7. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC, Wang Y, MacDonald JK, Hanauer S.
    Cochrane Database Syst Rev; 2016 Jul 03; 7(7):CD008870. PubMed ID: 27372735
    [Abstract] [Full Text] [Related]

  • 8. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    Timmer A, McDonald JW, Tsoulis DJ, Macdonald JK.
    Cochrane Database Syst Rev; 2012 Sep 12; (9):CD000478. PubMed ID: 22972046
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V, Wang Y, MacDonald JK, McDonald JW, Chande N.
    Cochrane Database Syst Rev; 2014 Aug 26; 2014(8):CD006884. PubMed ID: 25157445
    [Abstract] [Full Text] [Related]

  • 10. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E, Macdonald JK, Sutherland LR.
    Cochrane Database Syst Rev; 2010 Jun 16; (6):CD000545. PubMed ID: 20556747
    [Abstract] [Full Text] [Related]

  • 11. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E, Macdonald JK, Sutherland LR.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD000545. PubMed ID: 19821270
    [Abstract] [Full Text] [Related]

  • 12. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    Timmer A, Patton PH, Chande N, McDonald JW, MacDonald JK.
    Cochrane Database Syst Rev; 2016 May 18; 2016(5):CD000478. PubMed ID: 27192092
    [Abstract] [Full Text] [Related]

  • 13. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D, Macdonald JK, Chande N.
    Cochrane Database Syst Rev; 2014 Feb 21; (2):CD010410. PubMed ID: 24558033
    [Abstract] [Full Text] [Related]

  • 14. Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.
    Boyapati RK, Torres J, Palmela C, Parker CE, Silverberg OM, Upadhyaya SD, Nguyen TM, Colombel JF.
    Cochrane Database Syst Rev; 2018 May 12; 5(5):CD012540. PubMed ID: 29756637
    [Abstract] [Full Text] [Related]

  • 15. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    Khanna R, Preiss JC, MacDonald JK, Timmer A.
    Cochrane Database Syst Rev; 2015 May 05; (5):CD007572. PubMed ID: 25942580
    [Abstract] [Full Text] [Related]

  • 16. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM, Parker CE, MacDonald JK, Nguyen TM, Jairath V, Feagan BG, Khanna R.
    Cochrane Database Syst Rev; 2019 Feb 07; 2(2):CD012730. PubMed ID: 30731030
    [Abstract] [Full Text] [Related]

  • 17. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG, Macdonald JK.
    Cochrane Database Syst Rev; 2012 Oct 17; 10():CD000543. PubMed ID: 23076889
    [Abstract] [Full Text] [Related]

  • 18. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y, Parker CE, Bhanji T, Feagan BG, MacDonald JK.
    Cochrane Database Syst Rev; 2016 Apr 21; 4(4):CD000543. PubMed ID: 27101467
    [Abstract] [Full Text] [Related]

  • 19. Low dose naltrexone for induction of remission in Crohn's disease.
    Parker CE, Nguyen TM, Segal D, MacDonald JK, Chande N.
    Cochrane Database Syst Rev; 2018 Apr 01; 4(4):CD010410. PubMed ID: 29607497
    [Abstract] [Full Text] [Related]

  • 20. Adalimumab for maintenance of remission in Crohn's disease.
    Townsend CM, Nguyen TM, Cepek J, Abbass M, Parker CE, MacDonald JK, Khanna R, Jairath V, Feagan BG.
    Cochrane Database Syst Rev; 2020 May 16; 5(5):CD012877. PubMed ID: 32413933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.